These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1676251)

  • 21. Maintenance of CD4+ cells by thymopentin in asymptomatic HIV-infected subjects: results of a double-blind, placebo-controlled study.
    Conant MA; Calabrese LH; Thompson SE; Poiesz BJ; Rasheed S; Hirsch RL; Meyerson LA; Kremer AB; Wang CC; Goldstein G
    AIDS; 1992 Nov; 6(11):1335-9. PubMed ID: 1361746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomised double blind controlled trial.
    Kelly P; Lungu F; Keane E; Baggaley R; Kazembe F; Pobee J; Farthing M
    BMJ; 1996 May; 312(7040):1187-91. PubMed ID: 8634560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.
    Crumpacker C; Heagy W; Bubley G; Monroe JE; Finberg R; Hussey S; Schnipper L; Lucey D; Lee TH; McLane MF
    Ann Intern Med; 1987 Nov; 107(5):664-74. PubMed ID: 3662279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group.
    Roberts RB; Dickinson GM; Heseltine PN; Leedom JM; Mansell PW; Rodriguez S; Johnson KM; Lubina JA; Makuch RW
    J Acquir Immune Defic Syndr (1988); 1990; 3(9):884-92. PubMed ID: 1974628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study.
    Hersh EM; Brewton G; Abrams D; Bartlett J; Galpin J; Gill P; Gorter R; Gottlieb M; Jonikas JJ; Landesman S
    JAMA; 1991 Mar; 265(12):1538-44. PubMed ID: 1671884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.
    Lancet; 1994 Apr; 343(8902):871-81. PubMed ID: 7908356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Didanosine: long-term follow-up of patients in a phase 1 study.
    Lambert JS; Seidlin M; Valentine FT; Reichman RC; Dolin R
    Clin Infect Dis; 1993 Feb; 16 Suppl 1():S40-5. PubMed ID: 8093846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
    Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
    Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients.
    Blatt SP; Hendrix CW; Butzin CA; Freeman TM; Ward WW; Hensley RE; Melcher GP; Donovan DJ; Boswell RN
    Ann Intern Med; 1993 Aug; 119(3):177-84. PubMed ID: 8100691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
    AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose intravenous immunoglobulins in HIV-1-infected adults with AIDS-related complex and Walter-Reed 5.
    Schrappe-Bächer M; Rasokat H; Bauer P; Bendick C; Bube FW; Degenhardt S; Fätkenheuer G; Heiniger HJ; Heitmann K; Imbach P
    Vox Sang; 1990; 59 Suppl 1():3-14. PubMed ID: 1978443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
    Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
    Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial.
    Browne MJ; Mayer KH; Chafee SB; Dudley MN; Posner MR; Steinberg SM; Graham KK; Geletko SM; Zinner SH; Denman SL
    J Infect Dis; 1993 Jan; 167(1):21-9. PubMed ID: 8093363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of zidovudine dosing.
    Stoukides CA; Cichocki TJ
    Ann Pharmacother; 1992 Jun; 26(6):784-5. PubMed ID: 1351766
    [No Abstract]   [Full Text] [Related]  

  • 38. Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.
    Murray HW; Squires KE; Weiss W; Sledz S; Sacks HS; Hassett J; Cross A; Anderson RE; Dunkle LM
    J Infect Dis; 1995 Mar; 171 Suppl 2():S123-30. PubMed ID: 7861017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.
    Merigan TC; Skowron G; Bozzette SA; Richman D; Uttamchandani R; Fischl M; Schooley R; Hirsch M; Soo W; Pettinelli C
    Ann Intern Med; 1989 Feb; 110(3):189-94. PubMed ID: 2536257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.
    National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group
    N Engl J Med; 1991 Jul; 325(2):73-80. PubMed ID: 1675763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.